📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Therapeutic gene editing of T cells to correct CTLA-4 insufficiency. (2022)

First Author: Fox TA

Attributed to: CD96 a new immunoregulatory molecule - molecular mechanisms funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abn5811

PubMed Identifier: 36288278

Publication URI: http://europepmc.org/abstract/MED/36288278

Type: Journal Article/Review

Volume: 14

Parent Publication: Science translational medicine

Issue: 668

ISSN: 1946-6234